Siyue Jia
National Health Commission Key Laboratory Of Enteric Pathogenic Microbiology
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Deep mutational scanning reveals the antibody escape and infectivity landscape of SARS-CoV-2 Omicron JN.1 and XEC receptor-binding domains.
Journal: Emerging microbes & infections
Published: June 22, 2026
Safety Profiles of Seasonal Influenza Vaccines in Chinese Children and Adolescents: A Pooled Analysis of Five Clinical Studies.
Journal: Infectious diseases and therapy
Published: May 16, 2026
Systemic immune profiling of heterologous versus homologous boosting of COVID-19 vaccination.
Journal: Journal of translational medicine
Published: November 25, 2025
A predictive model for rapid assessment of protective efficacy against emerging SARS-CoV-2 variants.
A predictive model for rapid assessment of protective efficacy against emerging SARS-CoV-2 variants.
Journal: Infectious Disease Modelling
Published: November 09, 2025
Deep Mutational Scanning in Immunology: Techniques and Applications.
Journal: Pathogens (Basel, Switzerland)
Published: September 11, 2025
The Factors Influencing the Incidence, Persistence, and Severity of Symptoms After SARS-CoV-2 Infection in Chinese Adults: A Case-Control Study.
Journal: Tropical medicine and infectious disease
Published: May 01, 2025
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.
Journal: Human vaccines & immunotherapeutics
Published: January 27, 2025
Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial.
Journal: BMC infectious diseases
Published: January 06, 2025
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial.
Journal: Expert review of vaccines
Published: November 11, 2024
Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China.
Journal: Nature communications
Published: September 21, 2024
A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China.
Journal: Frontiers in immunology
Published: June 27, 2024
Relative effectiveness of a heterologous booster dose with adenovirus type 5 vectored COVID-19 vaccine versus three doses of inactivated COVID-19 vaccine in adults during a nationwide outbreak of omicron predominance, in China: a retrospective, individually matched cohort-control study.
Journal: Emerging microbes & infections
Published: April 28, 2024
Last Updated: 09/26/2026